Exodus Point Capital Management, LP Ardelyx, Inc. Transaction History
Exodus Point Capital Management, LP
- $16.4 Billion
- Q3 2024
A detailed history of Exodus Point Capital Management, LP transactions in Ardelyx, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 921,711 shares of ARDX stock, worth $4.58 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
921,711
Previous 302,154
205.05%
Holding current value
$4.58 Million
Previous $2.24 Million
183.65%
% of portfolio
0.04%
Previous 0.02%
Shares
12 transactions
Others Institutions Holding ARDX
# of Institutions
220Shares Held
141MCall Options Held
1.08MPut Options Held
2M-
Janus Henderson Group PLC London, X021.5MShares$107 Million0.08% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$87.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.6MShares$67.6 Million0.0% of portfolio
-
State Street Corp Boston, MA12.1MShares$60.3 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C38.95MShares$44.5 Million0.07% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $769M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...